Akèy › Adenokasinom Ezofajyen › South Carolina
Etid klinik pou Adenokasinom Ezofajyen nan South Carolina
6 etid pou Adenokasinom Ezofajyen ap chèche patisipan nan sit nan South Carolina.
Vil nan South Carolina
Tèks ofisyèl etid la (Anglè)
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
- Ralph H Johnson VA Medical Center, Charleston
- Medical University of South Carolina, Charleston
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT06203600mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- Medical University of South Carolina, Charleston
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT05677490Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
- Medical University of South Carolina, Charleston
Ap rekrite
Laj 18 a 89 · Tout sèks · Mizajou Sep 11, 2026 · NCT05753748Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Research Site, Charleston
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07431281A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Charleston
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07182149A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- Prisma Health Cancer Institute, Greenville
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 15, 2026 · NCT06657144Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.